Media Center

Learn More

Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 Years and Older

Johnson & Johnson announces significant progress towards its climate goals—100% renewable electricity for all sites in the United States, Canada and Europe by 2023

Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World’s Most Vulnerable People through Novel Humanitarian Buffer

U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines

Latest Press Releases

Innovation

December 05, 2021

Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses

Innovation

December 03, 2021

Latest Phase 3 Data for First-in-Class TREMFYA^® (guselkumab) Demonstrates Significant and Durable Improvement in Signs and Symptoms of Active Psoriatic Arthritis while Maintaining its Safety Profile in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)

Innovation

November 30, 2021

Janssen Seeks Approval of IMBRUVICA^®(ibrutinib) in a Fixed-Duration Regimen for Patients with Untreated Chronic Lymphocytic Leukaemia (CLL)

Media Statement

November 30, 2021

Johnson & Johnson Discussions to License its COVID-19 Vaccine to Aspen Reach Advanced Stage

Our Company

November 30, 2021

Johnson & Johnson announces significant progress towards its climate goals – 100% renewable electricity for all sites in the United States, Canada and Europe by 2023

Media Statement

November 29, 2021

Johnson & Johnson to Evaluate Its COVID-19 Vaccine Against New Omicron COVID-19 Variant

See All Press Releases

In the Media?

Sign up for Johnson & Johnson company news and press releases delivered right to your inbox.

Sign Up
Contact Media Relations

September 21, 2016

Thank you for your interest in learning more about our company. We care about your questions and concerns.

Contact Us

5 Ways We're Helping Build a World of Well

Learn more about how we're helping build a world of well through efforts in five key areas of healthcare.

J&J Fast Facts

Our Company

We Work All Over the World

We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.

Get to know Johnson & Johnson

See All Fast Facts

Social Media

RT @ncl_tweets: We can't wait any longer to get vaccinated for #COVID19. Hear more from @sallygreenberg, Executive Director of the @ncl_twe…

JNJNews
#JNJ MedTech is committed to addressing disparities in healthcare. Hear more from Carla Calizaire, Global Leader, D… https://t.co/Vl0xQP65CO

JNJNews
#JNJ #COVID19 vaccine mix-and-match preliminary Phase 2 and sub-study data announced here: https://t.co/axYJgs9YHt… https://t.co/O5hryPfxQn

JNJNews

More From Johnson & Johnson

ON NOW

Health & Wellness

4 Things to Know About RSV in the Time of COVID-19

Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. Here's how to protect your family this season, and learn how Johnson & Johnson is working to keep us all safer from RSV.

ON NOW

Woman shows dapivirine ring to three young women

Innovation

This Ring May Just Help Protect Women Against HIV

For World AIDS Day, learn how a new tool will help give this group greater power to prevent HIV on a monthly basis.

ON NOW

Four pictures show a scientist; a mother and child; businesspeople shaking hands; a woman outside; and wind turbines

Internet Explorer is no longer supported by this website.

Media Center

Latest Press Releases

J&J Fast Facts

Social Media

More From Johnson & Johnson